Thursday, September 14, 2017 10:15 PM ET
Significant Insider Sales Reported in Shares of Acceleron Pharma (XLRN)
There was substantial level of selling of Acceleron Pharma shares today, as revealed in filings with the SEC. Five insiders — McLaughlin, Dr Sherman, Dr Quisel, Dr Kumar, and Rovaldi — sold 58,626 shares in the company having a market value of approximately $2,251,971. These are the first insider buy/sell trades in the past 90 days. Adding the most recent activity to this 90-day history indicates insider trades have averaged 11,725 shares per transaction.
Over the last 90 days, the number of insider buy/sell trades at Acceleron Pharma is above its 266-company peer group average. The Bio Therapeutic Drugs peer group saw 291 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Acceleron Pharma insiders is lower than its peers. Within the peer group there were 7,588,255 shares purchased and 16,250,471 shares sold with company insiders disposing of 29,767 shares on average over this time period.
For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to evaluate and write this story.
Today’s Insider Activity
* Kevin F McLaughlin, Officer, sold 16,000 shares
* Dr Matthew L Sherman, Officer, sold 18,400 shares
* Dr John D Quisel, Officer, sold 5,113 shares
* Dr Ravindra Kumar, Officer, sold 5,113 shares
* Christopher Rovaldi, Officer, sold 14,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.